E46: Atul Rustgi of Accolade on What is LP Value-Add and Can it Lead to Alpha?

Atul Rustgi sits down with David Weisburd to discuss his role as a GP & LP, the paradoxes of selling and building relationships in VC, and the strategy of focusing on funds under $100 million. They also delve into including biotech as a diversification strategy, the importance of blockchain and crypto exposure, family office investments, and the challenges and rewards of raising a fund during a market downturn.

Speakers

AI Chat

Atul Rustgi

Guest • 75%

David Weisburd

Host • 25%

Chapters

0:00	Episode Preview
0:45	Introduction of Guest - Atul Rustgi: Role and Responsibilities as a GP
3:30	Discussion on the Paradoxes of Selling and Relationship Building in VC
6:03	Strategy Behind Focusing on Funds Under $100 Million and the Math Behind Ownership
11:14	Biotech as a Means to Diversify and Generate Alpha in VC
16:01	Sponsor: Deel
16:43	Blockchain and Crypto: The Importance of Exposure
21:03	Family Office Direct Investments and The Value of Reference Calls
24:57	Raising a Fund During a Market Downturn: Challenges and Rewards
26:17	10X Capital Podcast Newsletter
26:42	Lessons Learned from a Long Career in Venture Capital by Atul Rustgi

Transcript

Clip

Loading transcript...